Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Mobius Therapeutics LLC

Mobius Therapeutics LLC Recalls

All product recalls associated with Mobius Therapeutics LLC.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

304

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 4121–4140 of 4747 recalls

Mitosol Ophthalmic Solution (Mobius) – Contamination Risk (2013)

Non-Sterility: one or more components of the kit have been found to be contaminated with yeast.

Class IHigh

FDAJan 3, 2013Nationwide• Mobius Therapeutics LLC

Rugby Iron Supplement (Advance) – Label Mixup (2012)

Labeling; Label Mixup; bottles of Ferrous Sulfate actually contains Meclizine HCl (indicated for motion sickness)

Class IHigh

FDADec 28, 2012Nationwide• Advance Pharmaceutical Inc

12-Hour Sinus Nasal Spray (Lee) – Microbial Contamination (2012)

Microbial Contamination of a Non-Sterile Products: 12-Hour Sinus Nasal Spray under various labeling are being recalled due to microbial contamination identified during testing.

1...205 206207208 209...238

Page 207 of 238Next

Class II

Moderate

FDADec 21, 2012Nationwide• Lee Pharmaceuticals, Inc

Arctic Cat Bearcat Snowmobiles – fire risk (2012)

Fire/Burn Risk

The recall involves model year 2013 wide-track versions of the Arctic Cat Bearcat series. The Bearcat 570 XT and 570 WT have seats for an operator and a passenger. The model name and the letters "XT" or "WT" are on each side of the hood and the number "570" is near the rear of the tunnel on each side. Both vehicles have blue hoods. The Bearcat Z1 XT has seats for an operator and a passenger. The model name and the letters "XT" are on each side of the hood and "Z1" is near the rear of the tunnel on each side. It has a blue hood. The Bearcat Z1 XT GS is a single-rider vehicle. The model name and the letters "GS" are on each side of the hood and "Z1" is near the rear of the tunnel on each side. It has an orange hood, a winch on the front and a light bar located behind the operator's seat. The Bearcat Z1 XT LTD has seats for an operator and a passenger. The model name, the letters "XT" and the word "Limited" are on each side of the hood and "Z1" is near the rear of the tunnel on each side. It has a black hood and tunnel. Recalled vehicles have the last six digits of the vehicle identification number (VIN) in the following ranges: 808110 through 808130 and 108866 through 120615. The VIN appears on a sticker attached to the tunnel on the rider's right side and is also engraved in the same area.

CPSCDec 19, 2012Nationwide• Arctic Cat Inc., of Thief River Falls, Minn.

Taztia XT (Watson Pharmaceuticals) – Dissolution Failure (2012)

Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).

Class IIModerate

FDADec 18, 2012Nationwide• Watson Pharmaceuticals

Exparel (Pacira Pharmaceuticals) – Subpotent Medication (2012)

Subpotent; bupivacaine

Class IIModerate

FDADec 17, 2012Nationwide• Pacira Pharmaceuticals, Inc.

Lisinopril Tablets (West-ward Pharmaceutical) – Foreign Substance (2012)

Presence of Foreign Substance: Uncharacteristic black spots identified as a food grade lubricant with trace amounts of foreign particulates and stainless steel inclusions have been found in the tablets.

Class IIModerate

FDADec 7, 2012Nationwide• West-ward Pharmaceutical Corp.

Propylthiouracil Tablets (West-ward) - steel corrosion spots (2012)

Presence of Foreign Substance: Uncharacteristic spots identified as steel corrosion, degraded tablet material and hydrocarbon oil with trace amounts of iron were found in tablets.

Class IIModerate

FDADec 7, 2012Nationwide• West-ward Pharmaceutical Corp.

Carisoprodol Tablets (West-ward) - black tablet spots (2012)

Presence of Foreign Substance: Uncharacteristic blacks spots on tablets.

Class IIModerate

FDADec 7, 2012Nationwide• West-ward Pharmaceutical Corp.

RIDGID Coil Roofing Nailer (De Poan) – Laceration Risk (2012)

Laceration Risk

The recalled pneumatic nailers are used to secure fasteners into roofs and woodwork. The orange and gray hand held drill-shaped tools have the name "RIDGID" on the side of the nailers in white type on a black panel. The model and serial numbers are located on the side of the nail tray/magazine where the fasteners are loaded. Recalled nailers have the following serial number range: Coil Roofing Nailer model R175RNE: ER114600001 through ER1217008424 Clipped Head Framing Nailer model R350CHE: ER114600001 through ER1215004424. Nailers with a blue dot on the product packaging are not included in the recall.

CPSCDec 6, 2012Nationwide• De Poan Pneumatic Corporation, of Taiwan

Hydrocodone Acetaminophen (Qualitest) - oversized tablets (2012)

Superpotent (Multiple Ingredient) Drug: Complaint received of oversized tablets.

Class IHigh

FDADec 6, 2012Nationwide• Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals

Copaxone (Teva) - visible metal contamination (2012)

Presence of Foreign Substance: Product is being recalled due to receiving an elevated number of patient complaints related to a visible presence of medical grade silicone oil essential to the functionality of the syringe and plunger stopper system.

Class IIModerate

FDADec 5, 2012Nationwide• Teva Pharmaceuticals USA, Inc.

PredniSONE Tablets (West-ward) - gray tablet defects (2012)

Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.

Class IIModerate

FDADec 5, 2012Nationwide• West-ward Pharmaceutical Corp.

PredniSONE Tablets (West-ward) - black specks (2012)

Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.

Class IIModerate

FDADec 5, 2012Nationwide• West-ward Pharmaceutical Corp.

Dextroamphetamine Capsules (Amedra) - dissolution failure (2012)

Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

Class IIModerate

FDADec 4, 2012Nationwide• Amedra Pharmaceuticals LLC

Isoniazid Tablets (West-ward) - dissolution specification (2012)

Failed Dissolution Specifications; 36 month stability timepoint

Class IIModerate

FDADec 4, 2012GA• West-ward Pharmaceutical Corp.

Dextroamphetamine Capsules (Amedra) - dissolution failure (2012)

Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

Class IIModerate

FDADec 4, 2012Nationwide• Amedra Pharmaceuticals LLC

Dextroamphetamine Capsules (Amedra) - dissolution failure (2012)

Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

Class IIModerate

FDADec 4, 2012Nationwide• Amedra Pharmaceuticals LLC

Carisoprodol Tablets (West-ward) - DEA schedule change (2012)

Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled because this controlled product was not relabeled with the required "C-IV" imprint on the label for products distributed after the 06/11/12 deadline.

Class IIILow

FDANov 30, 2012Nationwide• West-ward Pharmaceutical Corp.

Ethambutol Tablets (West-ward) - tablet discoloration (2012)

Discoloration: Ethambutol Tablets USP 400 mg have tablets cores that may be discolored.

Class IIModerate

FDANov 30, 2012GA• West-ward Pharmaceutical Corp.